Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia;Klinische, biochemische und histopathologische veranderungen bei hepatitis-C-assozuerter kryoglobulinamie

Zeitschrift fur Gastroenterologie

Volumn 35, Issue 10, 1997, Pages 921-928

  Fayyazi, A ^a,b   Schott, P ^a   Hartmann, H ^a   Mihm, S ^a   Middel, P ^a   Ramadori, G ^a   Radzun, H J ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Cryoglobulinemia; HCV genotypes; Hepatitis C virus infection; Th2 response

Indexed keywords

CRYOGLOBULIN; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADULT; ANTIBODY PRODUCTION; ARTHRALGIA; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; ANTIBODY FORMATION; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; HEPATITIS C; HUMANS; IMMUNOGLOBULIN M; LIVER; LIVER CIRRHOSIS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RHEUMATOID FACTOR;

EID: 0030734307     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Weiner AJ, Christopherson C, Hall JE. Sequence variation in hepatitis C viral isolates. J Hepatol 1991; 13: 6-14
2. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis 1995; 15: 70-81
3. Di Bisceglie AM, Goodman ZD, Ishak KG et al. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969-74
4. Montano L, Aranguibel F, Boffill M et al. An analysis of the composition of the inflammatory infiltrate in autoimmune and hepatitis B virus-induced chronic liver disease. Hepatology 1983; 3: 292-6
5. Si L, Whiteside TL, van Thiel D, Rabin BS. Lymphocyte subpopulations at the site of »piecemeal« necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients. Lab Invest 1984; 50: 341-7
6. van den Oord JJ, Desmet VJ. Verteilungsmuster der Histokompatibilitäts-Hauptantigene im normalen und pathologischen Lebergewebe. Leber Magen Darm 1984; 14: 244-54
7. Desmet VJ. Liver lesions in hepatitis B viral infection. Yale J Biol Med 1988; 61: 61-83
8. Mosnier JF, Degott C, Marcellin P et al. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: An immunohistochemical study. Hepatology 1993; 17: 366-71
9. Gumber SC, Chopra S, Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-20
10. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569-70
11. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: A report of 86 cases. Am J Med 1974; 57: 775-88
12. Hartmann H, Schott P, Polzien F et al. Cryoglobulinemia in chronic hepatitis C virus infection: Prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates. Z Gastroenterol 1995; 33: 643-50
13. Meltzer M, Franklin E. Cryoglobulinemia: A study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med 1966; 40: 828-36
14. Del Prete G, De Carli M, D'Elios MM et al. CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J Exp Med 1995; 182: 1655-61
15. Del Prete G, Maggi E, Pizzolo G, Romagnani S. CD30. Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 1995; 16: 76-80
16. Caligaris Cappio F, Bertero MT, Converse M et al. Circulating levels of soluble CD 30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin Exp Rheumatol 1995; 13: 339-43
17. Pizzolo G, Romagnani S. CD30 molecule (Ki-1 Ag): More than just a marker of CD30+ lymphoma. Haematologica 1995; 80: 357-66
18. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 1996; 80: 225-35
19. Schubothe H, Westerhausen M. Nachweismethoden und Vorkommen von Kryoglobulinen. Dtsch Med Wochenschr 1970; 35:1786-8
20. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primer: Application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-9
21. Okamoto H, Tokita H, Sakamoto M et al. Characterization of the genomic sequence of type V (or 3 a) hepatitis C virus isolates and PCR primer for specific detection. J Gen Virol 1993; 74: 2385-90
22. Simmonds P, McOmish F, Yap PL et al. Sequence variability in the 5′ non-coding region of hepatitis C virus: Identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74: 661-8
23. Parwaresch MR, Radzun HJ, Feller AC, Peters KP, Hansmann ML. Peroxidase-positive mononuclear leukocytes as possible precursors of human dendritic reticulum cells. J Immunol 1983; 131: 2719-25
24. Cordell JL, Falini B, Erber WN et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-29
25. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5
26. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20
27. Lunel F, Musset L, Cacoub P et al. Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-300
28. Sinico RA, Ribero ML, Fornasieri A et al. Hepatitis C virus genotype in patients with essential mixed cryoglobulinemia. Q J Med 1995; 88: 805-810
29. Szakal AK, Kosco MH, Tew JG. Microanatomy of lymphoid tissue during humoral immune responses: Structure, function, relationships. Annu Rev Immunol 1989; 7: 91-110
30. Tew JG, Kosco MH, Szakal AK. The alternative antigen pathway. Immunol Today 1989; 10: 229-32
31. Kosco MH, Gray D. Signals involved in germinal center reactions. Immunol Rev 1992; 126: 63-76
32. Mazzaro C, Franzin F, Tulissi P et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy. Cancer 1996; 77: 2604-13
33. Zignego AL, Macchia D, Monti M et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992; 15: 382-8
34. Ferri C, Monti M, La Civita L et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701-4
35. Misiani R, Bellavita P, Fenili D et al. Interferon alfa-2 a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-6
36. Polzien F, Schott P, Mihm S, Ramadori G, Hartmann H. Interferon-α treatment of hepatitis C virus-associated mixed cryoglobulinemia. J Hepatol 1997; 27: 63-71